Suppr超能文献

高收入国家丙型肝炎病毒检测建议的比较。

Comparison of hepatitis C virus testing recommendations in high-income countries.

作者信息

Irvin Risha, Ward Kathleen, Agee Tracy, Nelson Noele P, Vellozzi Claudia, Thomas David L, Millman Alexander J

机构信息

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.

Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.

出版信息

World J Hepatol. 2018 Oct 27;10(10):743-751. doi: 10.4254/wjh.v10.i10.743.

Abstract

AIM

To investigate hepatitis C virus (HCV) testing recommendations from the United States and other high-income countries.

METHODS

A comprehensive search for current HCV testing recommendations from the top quartile of United Nations Human Development Index (HDI) countries (very high HDI) was performed using Google and reviewed from May 1 - October 30, 2014 and re-reviewed April 1 - October 2, 2017.

RESULTS

Of the 51 countries identified, 16 had HCV testing recommendations from a government body or recommendations issued collaboratively between a government and a medical organization. Of these 16 countries, 15 had HCV testing recommendations that were primarily risk-based and highlight behaviors, exposures, and conditions that are associated with HCV transmission in that region. In addition to risk-based testing, the HCV Guidance Panel (United States) incorporates recommendations for a one-time test for individuals born during 1945-1965 (the birth cohort) without prior ascertainment of risk into their guidance. In addition to the United States, six other countries either have an age-based testing recommendation or recommend one-time testing for all adults independent of risk factors typical of the region.

CONCLUSION

This review affirmed the similarities of the HCV Guidance Panel's guidance with those of recommendations from very high HDI countries.

摘要

目的

调查美国及其他高收入国家的丙型肝炎病毒(HCV)检测建议。

方法

利用谷歌对联合国人类发展指数(HDI)排名前四分之一的国家(极高HDI)当前的HCV检测建议进行全面检索,并于2014年5月1日至10月30日进行审查,2017年4月1日至10月2日再次审查。

结果

在确定的51个国家中,16个国家有政府机构发布的HCV检测建议,或政府与医疗组织联合发布的建议。在这16个国家中,15个国家的HCV检测建议主要基于风险,并突出该地区与HCV传播相关的行为、暴露情况和条件。除了基于风险的检测外,HCV指导小组(美国)在其指导意见中纳入了对1945年至1965年出生的人群(出生队列)进行一次性检测的建议,而无需事先确定风险。除美国外,其他六个国家要么有基于年龄的检测建议,要么建议对所有成年人进行一次性检测,而不考虑该地区典型的风险因素。

结论

本综述证实了HCV指导小组的指导意见与极高HDI国家建议的相似性。

相似文献

1
Comparison of hepatitis C virus testing recommendations in high-income countries.
World J Hepatol. 2018 Oct 27;10(10):743-751. doi: 10.4254/wjh.v10.i10.743.
4
NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19(3):1-46.
5
Implementing Updated Recommendations on Hepatitis C Virus Screening: Translating Federal Guidance Into State Practice.
J Public Health Manag Pract. 2017 Mar/Apr;23(2):169-174. doi: 10.1097/PHH.0000000000000266.
10
Birth Cohort Testing for Hepatitis C Virus - Indian Health Service 2012-2015.
MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):467-9. doi: 10.15585/mmwr.mm6518a3.

引用本文的文献

2
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations.
Appl Health Econ Health Policy. 2022 Mar;20(2):171-183. doi: 10.1007/s40258-021-00694-w. Epub 2021 Dec 6.
3
Hepatitis C Virus Screening: Factors Associated With Test Completion in a Large Academic Health Care System.
Public Health Rep. 2022 Nov-Dec;137(6):1136-1145. doi: 10.1177/00333549211054085. Epub 2021 Oct 25.
4
Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection.
J Clin Transl Hepatol. 2020 Mar 28;8(1):25-41. doi: 10.14218/JCTH.2019.00059. Epub 2020 Mar 24.

本文引用的文献

1
Recommendations on hepatitis C screening for adults.
CMAJ. 2017 Apr 24;189(16):E594-E604. doi: 10.1503/cmaj.161521.
3
Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
J Viral Hepat. 2016 May;23(5):366-74. doi: 10.1111/jvh.12507. Epub 2016 Feb 3.
4
Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.
Gastroenterol Clin North Am. 2015 Dec;44(4):825-43. doi: 10.1016/j.gtc.2015.06.001. Epub 2015 Aug 11.
5
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612. Epub 2015 Nov 17.
7
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.
PLoS One. 2014 Jul 2;9(7):e101554. doi: 10.1371/journal.pone.0101554. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验